Cite
HARVARD Citation
Nicol, B. et al. (2018). An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8+ T cells involved in multiple sclerosis. Journal of autoimmunity. pp. 61-74. [Online].